Webinar: Safer Medical Devices – In Vitro Assays As Part of a Biological Evaluation

In this webinar, the speakers will discuss the uses of in vitro assays as a part of the risk assessment and biological evaluation for the following endpoints: cytotoxicity, skin irritation and skin sensitization. Key topics The presentation will introduce biological evaluation and biocompatibility testing of medical devices, with focus on in vitro assays for skin irritation and skin sensitization now implemented in […]

Webinar: Recap on SenzaGen’s Eurotox Industry Symposium

Filling data gaps in skin sensitization testing: In vitro hazard and potency assessment using GARD In case you missed SenzaGen's industry symposium at this year's Eurotox Virtual Congress, here is a new opportunity! Together with guest speakers from Corteva Agriscience and Essity Hygiene & Health, we will present customer cases where the in vitro GARD assays have […]

Webinar: Safety Testing of Cosmetic Products

An Overview of Established Methods and New Approach Methodologies (NAMs) In this joint webinar,  we will present an overview of established methods and New Approach Methodologies (NAMs) used in the safety testing of cosmetic products. The webinar will start with a recorded presentation followed by a live Q&A session. If you cannot attend the live […]

Webinar: Why Choose GARD™ for Skin Sensitization Testing?

High performance, broad applicability, quantitative potency Join us for this webinar to get the latest news about the in vitro GARD assays and how they are used to fill data gaps and address challenges in skin sensitization testing, such as “difficult-to-test” substances, quantitative potency assessment, testing of medical devices and solid materials. Key topics An […]

Webinar: Recap on SenzaGen’s 2022 SOT Scientific Session

New GARD® data on agrochemical formulations, fragrance materials, medical devices and metals  - Skin sensitization: using in vitro tools for quantitative potency assessment as an alternative to the Local Lymph Node Assay In case you missed SenzaGen’s scientific session at this year’s SOT, here is a new opportunity! Together with guest speakers from Takasago and […]

Webinar: Medical devices’ principal mode of action by physical means

Case studies on 3D reconstructed human tissues This webinar will showcase the opportunities offered by 3D reconstructed human tissues to demonstrate the physical mode of action of medical devices in line with the requirements and ethical criteria of the EU Medical Devices Regulation (MDR) 2017/745. Key takeaways Attendees will gain insights into: 💡 How the principles […]

Webinar: OECD update

Join this live webinar led by our skin sensitization specialist Dr Andy Forreryd to learn the features and benefits of GARDskin and how the method can be used to fill data gaps during regulatory testing and product development. GARDskin approved by OECD We are delighted to announce that SenzaGen's GARDskin assay has been adopted by […]

Webinar: Recap on SenzaGen’s 2022 ICT Scientific Session

New GARD® data on agrochemicals,"difficult-to-test" substances and potency assessments  - In vitro skin sensitization testing: New opportunities for hazard and quantitative potency assessment using genomics and machine learning technology In case you missed SenzaGen’s scientific session at this year’s ICT, we are pleased to offer you a new opportunity! We will present new scientific data […]